Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 24;17(Suppl 1):2335492.
doi: 10.1080/20523211.2024.2335492. eCollection 2024.

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines

Sabine Vogler  1 , Nina Zimmermann  1 , Manuel Alexander Haasis  1 , Verena Knoll  1 , Jaime Espin  2 , Aukje K Mantel-Teeuwisse  3 , Dimitra Panteli  4 , Fatima Suleman  5 , Veronika J Wirtz  6 , Zaheer-Ud-Din Babar  7
Affiliations
Editorial

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines

Sabine Vogler et al. J Pharm Policy Pract. .

Abstract

Sustainable access to affordable medicines remains a public health issue globally, including for high-income countries. To foster the debate on avenues for the future, the fifth PPRI Conference held in Vienna on 25 and 26 April 2024 will offer a forum for the debate on innovating pharmaceutical policymaking to develop and implement futureproof policy options, which are able to address current and future challenges. The Conference invites a broad audience of stakeholders, including researchers, policymakers, payers, patients, industry and health professionals. The conference topics are organised in three strands: Strand 1 on 'Local challenges, global learnings' aims to contribute to lively discussions on the implementation of pharmaceutical policies across the globe. Best-practice examples will be presented, supplemented by case studies of less effective policies which can offer rich learnings. Strand 2 on 'Strengthening the evidence base' is the place for presentations and discussions on topics such as health technology assessments, managed entry agreements and real-world data. Strand 3 'Futureproofing pharmaceutical policies' is particularly dedicated to explore innovation in policymaking to achieve sustainable access to affordable medicines.

PubMed Disclaimer

References

    1. Anderson, M., Panteli, D., van Kessel, R., Ljungqvist, G., Colombo, F., & Mossialos, E. (2023). Challenges and opportunities for incentivising antibiotic research and development in Europe. The Lancet Regional Health–Europe, 33, 100705. - PMC - PubMed
    1. Brinkhuis, F., Goettsch, W. G., Mantel-Teeuwisse, A. K., & Bloem, L. T. (2024). Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: Retrospective cohort study. BMJ, e077391. - PMC - PubMed
    1. Davis, C., Naci, H., Gurpinar, E., Poplavska, E., Pinto, A., & Aggarwal, A. (2017). Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: Retrospective cohort study of drug approvals 2009–13. BMJ, 359(359), j4530. doi:10.1136/bmj.j4530 - DOI - PMC - PubMed
    1. Murray, C. J. L., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasi-Kangevari, M., Abd-Allah, F., Abdollahi, M., Abedi, P., Abedi, A., Abolhassani, H., Aboyans, V., Abreu, L. G., Abrigo, M. R. M., Abu-Gharbieh, E., Abu Haimed, A. K., Abushouk, A. I., Acebedo, A., Ackerman, I. N., Adabi, M., … Lim, S. S. (2020). Five insights from the global burden of disease study 2019. The Lancet, 396(10258), 1135–59. doi:10.1016/S0140-6736(20)31404-5 - DOI - PMC - PubMed
    1. Romanello, M., Di Napoli, C., Drummond, P., Green, C., Kennard, H., Lampard, P., Scamman, D., Arnell, N., Ayeb-Karlsson, S., Ford, L. B., Belesova, K., Bowen, K., Cai, W., Callaghan, M., Campbell-Lendrum, D., Chambers, J., van Daalen, K. R., Dalin, C., Dasandi, N., … Costello, A. (2022). The 2022 report of the Lancet Countdown on health and climate change: Health at the mercy of fossil fuels. The Lancet, 400(10363), 1619–54. doi:10.1016/S0140-6736(22)01540-9 - DOI - PMC - PubMed

Publication types

LinkOut - more resources